FMF Genotype-phenotype correlation in Iranian Azeri Turks: Association between M694V/R761H mutation and amyloidosis

Morteza Jabbarpour Bonyadi1, Mohammad Hossein Somi2, Mir Milad Pourmousavi Khoshknab2

  • 1Faculty of Natural Sciences, Center of Excellence for Biodiversity, University of Tabriz, Tabriz, Iran.

Abstract

Insights

Familial Mediterranean fever (FMF) in Iranian Azeri Turks shows common symptoms like peritonitis and fever. Specific MEFV gene mutations, not M694V, are linked to amyloidosis development.

Area of Science:

  • Genetics
  • Rheumatology
  • Internal Medicine

Background:

  • Familial Mediterranean fever (FMF) is an inherited autosomal recessive autoinflammatory disorder prevalent in Mediterranean populations.
  • Clinical manifestations of FMF can vary significantly across different ethnic groups.
  • Understanding ethnic-specific FMF characteristics is crucial for accurate diagnosis and management.

Purpose of the Study:

  • To identify the most common clinical features of FMF in an Iranian Azeri Turk population.
  • To investigate the association between specific MEFV gene mutations and clinical findings in this cohort.
  • To correlate genotype with the risk of developing AA amyloidosis.

Main Methods:

  • Clinical and genetic data from 415 FMF patients were analyzed.
  • Patients were referred to the Molecular Genetics Laboratory in Tabriz, Iran.
  • Mutation types and clinical characteristics were systematically recorded over three years.

Main Results:

  • The most frequent symptoms included peritonitis (93.8%), high-grade fever (86.88%), and arthritis (54.57%).
  • AA amyloidosis was observed in 40.16% of patients.
  • A positive response to colchicine treatment was noted in 95.1% of patients.

Conclusions:

  • Contrary to some studies, the M694V mutation was not significantly associated with amyloidosis.
  • Specific genotypes (M680I/M680I, M680I, M694I, M694V/R761H) were linked to amyloidosis development.
  • Physicians should monitor FMF patients with these genotypes closely, even if asymptomatic or mildly symptomatic.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
112
Background and Environment Affect Phenotype02:27

Background and Environment Affect Phenotype

Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
8.1K
Genetic Lingo01:11

Genetic Lingo

Overview
118.1K
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.9K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
68
Pedigree Analysis01:35

Pedigree Analysis

Overview
91.1K